ORIFARM GROUP A/S: Financial statements 2014
CVR: 27347282
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
ORIFARM GROUP A/S (CVR 27347282) has filed annual accounts for 2014. In 2014, the company reported revenue of EUR 11,395,000 and a net result of EUR 6,229,000 compared with EUR 6,225,000 the year before. That is a decrease of 4.5% compared with the year before. The profit margin was 54.7%. Equity in the 2014 report amounted to EUR 60,387,000. The solvency ratio was 38.1%.
- Revenue
- EUR 11,395,000
- Gross Profit
- EUR 11,505,000
- Profit/Loss
- EUR 6,229,000
- Equity
- EUR 60,387,000
- Total Assets
- EUR 158,409,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 11.4 mio. EUR | 11.5 mio. EUR | 6.2 mio. EUR | 60.4 mio. EUR | - |
| 2013 | 11.9 mio. EUR | 11.9 mio. EUR | 6.2 mio. EUR | 55.8 mio. EUR | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
ORIFARM GROUP A/S has published its annual report for 2013. Revenue came to DKK 11,928,000, and the net result was DKK 6,225,000.
As of May 20, 2014, Lars Monrad-Gylling has joined the board of directors of ORIFARM GROUP A/S.
As of May 20, 2014, Claudio Albrecht has joined the board of directors of ORIFARM GROUP A/S.
As of May 20, 2014, Carsten Fode has left the board of directors of ORIFARM GROUP A/S.
As of April 8, 2014, Søren Larsen has joined the board of directors of ORIFARM GROUP A/S.
As of April 8, 2014, Maria Lefevre Borch has joined the board of directors of ORIFARM GROUP A/S.
As of April 8, 2014, Hans Christian Eberhard Groth Teisen has stepped down as økonomidirektør of ORIFARM GROUP A/S.
As of April 8, 2014, Peter Raupach Linnet has stepped down as director of ORIFARM GROUP A/S.
As of January 1, 2014, Karsten Dybmose Truelsen has joined the board of directors of ORIFARM GROUP A/S.
As of January 1, 2014, Karsten Dybmose Truelsen has left the board of directors of ORIFARM GROUP A/S.
About ORIFARM GROUP A/S
ORIFARM GROUP A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Ikke-finansielle hovedsæders aktiviteter. The company was previously named CAREFARM A/S. The management consists of Mads Fink Eriksen and Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Ole Michael Friis, Adeel Ahmad and Bettina Britt Juel Hansen. The company is owned by Orifarm Holding A/S. The company has 211 employees (2026). In 2025, the company reported a gross profit of EUR 1,478,000 and a net result of EUR 51,761,000 compared with EUR 3,260,000 the year before. Equity in the 2025 report amounted to EUR 413,677,000.